Hematology
New bleeding risk scheme, HEMORR2 HAGES, quantifies hemorrhage risk in antithrombotic therapy
Published in Blood Weekly, May 25th, 2006
According to a recent report in the American Heart Journal, "Although warfarin and other anticoagulants can prevent ischemic events, they can cause hemorrhage. Quantifying the rate of hemorrhage is crucial for determining the risks and net benefits of prescribing antithrombotic therapy."
"Our objective was to find a bleeding classification scheme that could quantify the risk of hemorrhage in elderly patients with atrial fibrillation," wrote B.F....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-05-25)
More Articles from Blood Weekly
- Blood Banking
Whole-blood leukoreduction filters are a source for cryopreserved cells - Blood Banking
Whole-blood storage time affects the number of white cells and platelets - Cardiovascular Research
Simple formula predicts blood needs in heart surgery - Renal Regeneration
Intrarenal cells are the main source for renal regeneration - Stem Cell Transplantation
Early allogeneic hematopoietic stem cell transplant beneficial in inherited disorders - Alzheimer Disease
Blood-derived microglia prevent or eliminate amyloid deposits in Alzheimer disease - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
